Droia Ventures

Portfolio Companies 2026 for Droia Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Droia Ventures accounts for 10 tracked companies with verified cap-table data, 10 of which disclose round sizes totalling $1.1B. The median disclosed raise is $100M, and the largest is Protego Biopharma at $181M, ahead of Accent Therapeutics ($178M) and QurAlis ($144M).

The names that recur most often on these portfolio cap tables are Droia Ventures (10 companies), Novartis Venture Fund (2 companies), YK Bioventures (2 companies), Digitalis Ventures (2 companies), The Column Group (2 companies), Atlas Venture (2 companies). By latest disclosed round, the market skews Series A (6), Series B (3), Series C (1).

Best funded Droia Ventures companies

  1. Protego Biopharma — $181M (latest: Series B)
  2. Accent Therapeutics — $178M (latest: Series C)
  3. QurAlis — $144M (latest: Series B)
  4. AmbAgon Therapeutics — $103M (latest: Series A)
  5. Judo Bio — $100M (latest: Series A)
  6. Vico Therapeutics — $91M (latest: Series B)
  7. Muna Therapeutics — $73M (latest: Series A)
  8. Hillstar Bio — $67M (latest: Series A)
  9. Alesta Therapeutics — $67M (latest: Series A)
  10. Vicinitas Therapeutics — $65M (latest: Series A)

Droia Ventures — related firms and companies (53)

Droia Ventures profile · All research reports